Siga Technologies (SIGA) Depreciation & Amortization (CF) (2011 - 2025)
Siga Technologies' (SIGA) quarterly Depreciation & Amortization (CF) came in at $116089.0 in Q3 2025, up 7.8% on a YoY basis from $107692.0 in Q3 2024, and down 29.51% quarter-over-quarter from $164692.0 in Q2 2025.
Analysis
Siga Technologies (SIGA) Depreciation & Amortization (CF) (2011 - 2025) Analysis & Trends
Siga Technologies (SIGA) has reported Depreciation & Amortization (CF) for 15 consecutive years, with $116089.0 the latest figure, recorded in Q3 2025.
- For the quarter ending Q3 2025, Depreciation & Amortization (CF) rose 7.8% year-over-year to $116089.0; the trailing twelve-month figure through Dec 2025 stood at $416089.0 (down 22.72% YoY), and the FY2024 full-year result was $538421.0, changed 0.02% from the prior year.
- Depreciation & Amortization (CF) eased to $116089.0 in Q3 2025 per SIGA's latest filing, from $164692.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $172474.0 in Q2 2022 and bottomed at $100000.0 in Q3 2021.
- Historically, Depreciation & Amortization (CF) has averaged $133306.0 across 5 years, with a median of $130826.0 in 2021.
- The sharpest annual moves came in 2021 and 2023: Depreciation & Amortization (CF) fell 5.74% in 2021, then rose 16.96% in 2023.
- Over 5 years, Depreciation & Amortization (CF) stood at $122368.0 in 2021, then dropped by 3.86% to $117643.0 in 2022, then grew by 16.96% to $137591.0 in 2023, then dropped by 4.99% to $130729.0 in 2024, then declined by 11.2% to $116089.0 in 2025.
- According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $116089.0, $164692.0, and $135308.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 1.96 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | - |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | - |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | 1.62 Bn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | 3.97 Bn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 26.48 Mn |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn | 24.20 Mn |
| 10 | Siga Technologies | 235.60 Mn | 80.63 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 116,089.00 |
| Jun 30, 2025 | 164,692.00 |
| Mar 31, 2025 | 135,308.00 |
| Dec 31, 2024 | 130,729.00 |
| Sep 30, 2024 | 107,692.00 |
| Jun 30, 2024 | 161,529.00 |
| Mar 31, 2024 | 138,471.00 |
| Dec 31, 2023 | 137,591.00 |
| Sep 30, 2023 | 100,702.00 |
| Jun 30, 2023 | 168,879.00 |
| Mar 31, 2023 | 131,121.00 |
| Dec 31, 2022 | 117,643.00 |
| Sep 30, 2022 | 100,000.00 |
| Jun 30, 2022 | 172,474.00 |
| Mar 31, 2022 | 127,526.00 |
| Dec 31, 2021 | 122,368.00 |
| Sep 30, 2021 | 100,000.00 |
| Jun 30, 2021 | 169,174.00 |
| Mar 31, 2021 | 130,826.00 |
| Dec 31, 2020 | 129,814.00 |